Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1425 Inhibitors

Olr1425 inhibitors are a class of chemical compounds specifically designed to target and inhibit the Olr1425 receptor, an olfactory receptor that is part of the G protein-coupled receptor (GPCR) superfamily. These receptors are essential components of the olfactory system, which is responsible for detecting and processing odorant molecules, ultimately leading to the perception of various smells. Olr1425 inhibitors function by binding to the receptor's active site, where natural odorant molecules typically interact, or by engaging with allosteric sites that can modulate the receptor's activity. This binding action prevents the receptor from undergoing the conformational changes necessary to initiate the intracellular signaling pathways that are crucial for olfactory signal transduction. By inhibiting these processes, Olr1425 inhibitors effectively block the receptor's ability to transmit olfactory signals, thereby disrupting the normal functioning of the olfactory system in sensing and identifying odors. The development and design of Olr1425 inhibitors are often guided by detailed structural studies of the receptor, utilizing advanced techniques such as X-ray crystallography, molecular dynamics simulations, and cryo-electron microscopy. These structural insights are essential for creating inhibitors that are highly specific to the Olr1425 receptor and effective in modulating its activity without affecting other similar receptors.

Chemically, Olr1425 inhibitors exhibit a wide range of molecular structures, reflecting the diverse approaches taken in their design and synthesis. These inhibitors can vary from small, lipophilic molecules capable of easily crossing cellular membranes to reach their target receptors, to larger, more complex structures that may require advanced synthetic techniques to achieve optimal binding affinity and specificity. The synthesis of Olr1425 inhibitors typically involves multiple steps of organic chemistry, including the construction of molecular frameworks and the strategic incorporation of functional groups that enhance the compound's interaction with the receptor. Once synthesized, these inhibitors undergo rigorous characterization using a variety of analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods are employed to ensure the structural integrity, purity, and inhibitory potency of the compounds. The study of Olr1425 inhibitors is crucial for advancing our understanding of the specific mechanisms by which this olfactory receptor functions and how its activity can be modulated by small molecules. Additionally, this research contributes to the broader field of GPCR biology, offering valuable insights into the molecular processes underlying sensory perception, particularly in the context of olfaction. By deepening our knowledge of how olfactory receptors function and how they can be selectively targeted, scientists can explore new avenues in the study of sensory systems and the complex biochemical pathways that govern them.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic antagonist, might modulate GPCR activity, potentially affecting Olr1425.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$122.00
$235.00
$520.00
$979.00
$1500.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking, might influence Olr1425 signaling pathways.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

Alpha-2 adrenergic receptor antagonist, could affect GPCR signaling pathways related to Olr1425.

Labetalol

36894-69-6sc-484723
50 mg
$176.00
(0)

Combined alpha and beta blocker, might indirectly affect GPCR pathways including Olr1425.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr1425.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Beta-adrenergic agonist, might indirectly affect Olr1425 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$200.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr1425.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr1425.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Beta blocker, could indirectly influence GPCR signaling pathways including Olr1425.